CommentLessons from carotid endarterectomy and stenting trials
References (13)
- et al.
New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS)
Lancet Neurol
(2010) - et al.
Lancet
(2010) - et al.
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
Lancet Neurol
(2009) - et al.
Carotid-artery imaging in the diagnosis and management of patients at risk of stroke
Lancet Neurol
(2009) - et al.
Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study
Lancet Neurol
(2010) Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data
Lancet
(2010)
Cited by (25)
Stroke prevention
2019, Presse MedicaleDurability of eversion carotid endarterectomy
2014, Journal of Vascular SurgeryThe effect of statin use on embolic potential during carotid angioplasty and stenting
2013, Annals of Vascular SurgeryCitation Excerpt :Although there is significant progress in endovascular technology, multiple trials have failed to show equivalency in outcomes between carotid artery stenting (CAS) and carotid endarterectomy (CEA).1–3
Comparing the embolic potential of open and closed cell stents during carotid angioplasty and stenting
2012, Journal of Vascular SurgeryCitation Excerpt :An analysis of pooled data from the EVA-3S, SPACE, and ICSS clearly demonstrated an overall higher periprocedural risk of stroke and death with CAS compared to endarterectomy.8 Further stratification localized the higher periprocedural stroke and death rates to patients over 70 years of age (12.0% vs 5.9%; P = .0053).8 A similar increased stroke risk in patients >70 years of age was found in the CREST.6
Carotid endarterectomy and treatment options for carotid occlusive disease
2011, World NeurosurgeryCitation Excerpt :However, addressing the primary end point of any stroke, MI, or death up to 4 years after intervention, the null hypothesis was to be accepted (8, 21). The inclusion of asymptomatic cardiac ischemia as a primary end point in CREST has been criticized by a number of commentators (3). Silent cardiac events are not generally used as an end point in comparable contemporary European trials (3).
Just when we thought we knew all the answers, someone changed the questions!
2011, European Journal of Vascular and Endovascular Surgery